Analysis of discrepancies of core needle biopsy and surgical specimens for accurate evaluation of hormonal receptors and epidermal growth factor receptor 2 status of invasive breast cancer patients
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh J. ComberH at al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer. 2013;1374–403.
2.
Christopher J, Cimino-Mathews A, Park B, Emens L, Tsangaris T, Argani P. Reflex Estrogen receptor/Progesteron receptor/Human epidermal growth factor receptor 2 (Er/PR/Her2) Analysis of Breast Cancers in Needle Core Biopsy Specimens Dramaticlly Increases Health Care Costs. Am Surg Pathol. 2015;939–47.
3.
Dekker T, Smit V, Hooijer G, Van De Vijver M, Mesker V. Tollenaar RAEM at al. Reliability of core needle biopsy for determining ER and HER2 status in breast cancer. Ann Oncol. 2012;1–7.
4.
Kentaro T, Sasano H, Ishida T, Takeda M, Amari M, Tamaki N. Comparison of core needle bipsy (CNB) and surgical specimens for accurate preoperative evaluation of ER, PgR, and HER 2 status for breast cancer patients. Cancer Sci. 2010;2074–9.
5.
Elston C, Ellis I. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;403–10.
6.
Allred D, Harvey J, Berardo M, Clark G. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998;155–68.
7.
Andrade V, Gobbi H. Accuracy of typing and grading invasive mammary carcinomas on core needle biopsy compared with the excisional specimen. Virchows Arch. 2004;597–602.
8.
Sharifi S, Peterson M, Baum J, Raza S, Schnitt S. Assessment of pathologic prognostic factors in breast core needle biopsies. Mod Pathol. 1999;941–5.
9.
Harris G, Denley H, Pinder S, Lee A, Ellis I, Elston C. Correlation of histologic prognostic factors in core biopsies and therapeutic excisions of invasive breast carcinoma. Am J Surg Pathol. 2003;11–5.
10.
Monticciolo D. Histologic grading at breast core needle biopsy: comparison with results from the excised breast specimen. Breast J. 2005;9–14.
11.
Badoual C, Maruani A, Ghorra C, Lebas P, Avigdor S, Michenet P. Pathological prognostic factors of invasive breast carcinoma in ultrasound-guided large core biopsies. A correlation with subsequent surgical excisions. Breast. 2005;22–7.
12.
Xiaosong C, Long S, Yan M, Siji Z, Siji Z, Jiayi W. Preoperative core needle biopsy is accurate in determining molecular subtypes in invasive breast cancer. BMC Cancer. 2013;390–6.
13.
Sutela A, Vanninen R, Sudah M, Berg M, Kiviniemi V, Rummukainen J. Surgical specimen can be replaced by core samples in assessment of ER, PR and HER-2 for invasive breast cancer. Acta Oncol. 2008;38–46.
14.
Douglas-Jones, Collett A, Morgan N, Jasani J, B. Comparison of core oestrogen receptor (ER) assay with excised tumour: intratumoral distribution of ER in breast carcinoma. J Clin Pathol. 2001;951–5.
15.
Wojnar A, Pula B, Okolow P, Dziegiel M, P. Discrepancies between HER2 assessment from core needle biopsies and surgical specimens of invasive ductal breast carcinoma. Adv Clin Exp Med. 2013;27–31.
16.
Park Y, Youk J, Son E, Gweon H, Kim J. Comparison of hormonal receptor and 17. HER2 status between ultrasound-guided14-gauge core needle biopsy and surgery in breast cancer patients. Ultrasonography. 2014;206–15.
17.
Sarode V, Xiang O, Md; Alana M, Collins R, Rao R, Leitch A. Evaluation of HER2/neu Status by Immunohistochemistry Using Computer-Based Image Analysis and Correlation With Gene Amplification by Fluorescence In Situ Hybridization Assay. Arch Pathol Lab Med. 2015;922–8.
18.
Stoss O, Scheel A, Nagelmeier I, Schildhaus H, Henkel T, Viale T, et al. Impact of updated HER2 testing guidelines in breast cancer-re-evaluation of HERA trial fluorescence in situ hybridization data. Mod Pathol. 2015;281528–34.
Citation
Copyright
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
